INTRODUCTION
Glucose and fructose transepithelial absorption in the small intestine involves specific transport proteins located in the brush border and basolateral membrane of the enterocytes. These transporters belong to distinct families of transporters: the Naactivated transporters with the Na/glucose cotransporter, encoded by the SGLT1 gene [1, 2] , and two members of the GLUT facilitative transporter family [3, 4] with GLUT5 [5] , i.e. a brush border membrane-associated protein [6, 7] shown to have a fructose transport activity in human [8] and rat [9] cells, and GLUT2 which is involved in the translocation of glucose and fructose from the cytoplasm to the bloodstream across the basolateral membrane [10, 11] .
Studies designed to characterize the functional adaptation of sugar transporters in animal models have provided evidence for specific dietary sugar regulation of the expression of sugar transport proteins [12] [13] [14] [15] [16] . Indeed fructose transport was increased in the small intestinal cells of animals fed fructoseenriched diets, this sugar being the best inducer of its own uptake [17] . These observations were confirmed at the molecular level in rat small intestine, where fructose-but not glucose-enriched diets were shown to increase the mRNA and protein abundances of GLUT5 [18] [19] [20] .
The human colon carcinoma cell line Caco-2 displays in culture, after confluency, the morphological and functional features of mature enterocytes (for review see [21] ), including the expression of proteins involved in the absorption of sugar nutrients: they express sucrase-isomaltase [22] , the Na/glucose cotransporter SGLT1 [23] , GLUT2 and GLUT5 [7, 24] as well as GLUT1 and GLUT3 [24, 25] . Although these are cancer cells, and as such have a peculiar metabolism ofglucose, they constitute a unique human model in vitro to study the regulation of the expression of sugar transporters.
Little is known about the regulation of the expression of the fructose transporter in the human intestine. Forskolin, a drug glucose-fed cells. Cells fed normal serum exhibited an inverse hierarchy of expression, with glucose being a better inducer than fructose for the expression of GLUT5. The GLUT5 mRNA and protein abundances obtained in fructose-fed cells did not depend on the type of serum. A linear relationship between cyclic AMP (cAMP) levels and GLUT5 mRNA abundance was found in cells fed dialysed serum, whereas in cells fed normal serum, mRNA abundances were not correlated to cAMP levels. These results indicate that glucose and fructose, together with serum-related factors and cAMP, have combined effects on the expression of GLUT5 in Caco-2 cells.
known to stimulate adenylate cyclase and increase the level of cellular cyclic AMP (cAMP) [26] , was shown to increase strongly the abundances of GLUT5 protein and mRNA in Caco-2 cells [27] . This effect occurs mainly at the transcriptional level, as assessed by the activity of the reporter gene luciferase placed under the control of DNA constructs containing the promoter region of GLUT5. The cAMP responsive element sequences present in the promotor could partially explain the stimulation of transcription of the gene. Indeed their deletion only reduced, but did not abolish, the stimulation of transcription of the reporter gene, indicating that additional elements for the regulation of GLUT5 are involved [27] . The increase in cAMP content of Caco-2 cells has important consequences for the metabolism of glucose, giving an enhanced glucose consumption rate and strong glycogenolysis [28] . These alterations could be involved in the, yet unexplained, increase in the transcription of the GLUT5 gene observed under forskolin treatment [27] . Moreover, the recent observations made in our laboratory, showing that the expression of GLUT5 is strongly dependent on the level of glucose consumption of clones of Caco-2 cells [24] , support-the idea that monosaccharides may be important for its regulation. Hexose transporter expression in the Caco-2/PD7 clone has been reported elsewhere [24] . In these cells, as in other clones that exhibit a low glucose consumption rate in the stationary phase of growth, GLUT5 mRNA and protein are expressed after confluency in differentiated cells and can be modulated by culture of these cells in low-glucose-containing media [24] .
This study describes the effect of the dietary monosaccharides, glucose and fructose, on GLUT5 mRNA and protein abundances in the Caco-2/PD7 clone.
MATERIALS AND METHODS Cell culture
The parental Caco-2 population [22] [29] . The PD7 clone was used in this study because of its high relative levels of expression of the hexose transporter mRNA SGLT1, GLUT2 and GLUT5 [24] . The cells were seeded at 12 x 103 cells/cm2 in 25 cm2 plastic flasks (Coming Glassworks, Coming, NY, U.S.A.) and cultured in a 10% C02/90 % air atmosphere in Dulbecco's modified Eagle's minimum essential medium (DMEM) (Eurobio, Paris, France) containing 25 mM glucose. The media were supplemented with 20 % heat-inactivated (30 min, 56 IC) fetal bovine serum (FBS; Boehringer, Mannheim, Germany) and 1 % non-essential amino acids (Gibco, Glasgow, Scotland, U.K.). This 'standard' medium was used to maintain the cell line which was passaged every 6 days. Under all culture conditions, the medium (0.2 ml/cm2) was changed 48 h after seeding and daily thereafter. Unless specified, all cells were harvested 24 h after a medium change.
For the purpose of this study, the cells were grown either in normal heat-inactivated FBS, yielding a final 1 mM glucose concentration, or in heat-inactivated serum that was dialysed (Mr cut-off 6000-8000) against saline and contained less than 100 ,uM glucose, yielding a final glucose concentration below 10 ,uM. Dialysed serum conditions were applied after day 10 of culture in the standard medium, so that the differentiation process was under way. Cells were then switched to the three different hexose conditions in dialysed serum. Two different lots of FBS were used. Culture media containing different sugars were made using hexose-free (Hf) DMEM which was supplemented with 25 mM glucose (G) or fructose (F). Detailed protocols of the cultures are given in the legends of the Figures.
cDNA probes and Northern blot analysis
The cDNA probe phJHT5/hGLUT5 (1.9 kb insert) was obtained from G. I. Bell (Howard Hughes Medical Institute, University of Chicago, Chicago, IL, U.S.A.) and DPI-101 (2.5 kb insert) (DPPIV; EC 3.4.14.5) from D. Darmoul [30] . Probes were 32P-labelled using a Megaprime DNA labelling kit (Amersham).
RNA analysis were performed on cells harvested at the indicated days of the culture. Total RNA was isolated using guanidium thiocyanate and centrifugation through a CsCl gradient [31] . Glyoxal-denatured samples of total RNA were fractionated by electrophoresis on 1 % (w/v) agarose gels and subsequently transferred to Hybond*-N membranes (Amersham). Hybridization of the membranes with 32P-labelled probes was carried out as described [32] . The membranes were washed using high-stringency conditions with a final 15 min wash in 0.1 x SSC/0.1 % (v/v) SDS (SSC = 0.15 M NaCl/0.015 M sodium citrate) at 65 IC before exposure of X-ray film.
Western blot analysis
Cell homogenates were prepared as described [7] . Briefly, the cells were scraped in cold 2 mM Tris/HCl, pH 7.1, and 50 mM mannitol containing 1 mM PMSF, 0.02% (v/v) sodium azide and 25 /tg/ml benzamidine as protease inhibitors. The cells were disrupted with a conical grinding tube and sonicated (15 s, 60 W). Protein samples (20,tg) were solubilized in Laemmli buffer as modified by Haspel et al. [33] and electrophoresed under denaturating conditions in 100% SDS-slab gels. Molecularmass markers (Rainbow Markers, Pharmacia) were run in parallel. Proteins were transferred to Hybond-ECL membranes (Amersham) by electroblotting, fixed and stained for visualization with 0.25 % (w/v) Ponceau S in 5 % trichloroacetic acid. The membranes were then allowed to react with the anti-(human GLUT5) antibody (ral668/9; 1:2000 dilution) prepared and characterized in our laboratory [7] . The primary antibody was detected using an anti-(rabbit Ig) antibody from goat (Pasteur Institute, Paris, France) and the luminol ECL detection system (Amersham).
Biochemical assays: glycogen content, glucose-and fructoseconsumption rates, lactate production, DPPIV activities and cAMP concentrations For glycogen assays, the cells were quickly rinsed with cold Ca2+/Mg2+-free PBS and scraped off the plastic support for subsequent extraction and measurement with anthrone, as previously reported [34] . Glucose consumption was determined by measuring the concentration of glucose in the medium 24 h after the medium change, using the glucose oxidase technique and a Beckman Glucose Analyzer 2. Fructose consumption rates were measured with the glucose/fructose assay kit (Boehringer, Mannheim, Germany) and protein with the BCA protein assay kit using BSA as a standard (Pierce, Rockford, IL, U.S.A.). DPPIV activities were assayed by measuring the hydrolysis of 1.5 mM glycyl-L-proline-4-nitroanilide, as described by Nagatsu et al. [35] . For cAMP assays the culture flasks were quickly emptied, frozen in liquid nitrogen and stored at -70 'C. Monolayers were extracted with ice-cold ethanol and spun at 2000 g for 15 min at 4 'C. Dried extracts were assayed with the Biotrak enzyme immunoassay system (Amersham, Les Ulis, France).
RESULTS
Glucose or fructose Is required for the expression of GLUT5 mRNA After 10 days of culture under the standard conditions, i.e. normal serum and 25 mM glucose, total glucose deprivation was 10 obtained by feeding the cells with glucose-free DMEM and dialysed serum. A rapid decrease of GLUT5 mRNA abundance, down to levels below detection, was observed within the first 4 days after the medium change (Figure 1 ). On the contrary, cells fed glucose and fructose and dialysed serum exhibited measurable GLUT5 mRNA abundances (Figure 1 ). However, GLUT5 mRNA abundance was significantly higher in fructose-than in glucose-fed cells. Stabilized levels were observed as soon as day 16, i.e. 5 days after the change in the sugar composition of the media. The abundance of DPPIV mRNA did not vary and was therefore used as an internal standard for Northern blot analysis. In order to test the reversibility of the down-regulation of GLUT5 mRNA expression in hexose-free media, cells were switched back to glucose or fructose media (Figure 2 ). GLUT5 mRNAs were detectable within 8 h, with fructose-fed cells exhibiting a higher abundance than glucose-fed cells. Conversely, in fructose-fed cells which express continuously high levels of GLUT5 (Figure 1 ), sugar deprivation as well as glucose feeding, down-regulated the expression of GLUT5 to a level identical with that obtained in cells fed the same medium continuously (results not shown).
The presence of increasing amounts of normal serum in the culture media of Caco-2 cells increases the expression of GLUT5 (results not shown). To compare further GLUT5 mRNA abundance in relation to hexose and type of serum (normal versus dialysed) in the culture media, 12 parallel subcultures were made using the different combinations of medium changes (see the legend to Figure 3) . The cells were harvested at day 30 of culture, 24 h after the medium change. In dialysed serum the GLUT5 Control of the abundance of GLUT5 protein GLUT5 protein was assayed by Western blotting (Figure 4) . After a transient increase of the protein in all samples (day 13), probably due to a time-lag in the response of protein biosynthesis after the medium changes, the abundance of the GLUT5 protein paralleled that of mRNA, suggesting that its expression is not regulated at the translational level ( Figure 5 ). This observation holds for cells that re-express GLUT5 mRNA, although the protein re-expression was delayed (results not shown). Transmission scanning of the Northern and Western blots confirmed that protein levels are correlated with mRNA abundance regardless of the serum used to grow the cells (Figure 6a ).
Hexose consumption rates, lactate production and glycogen and cAMP content in late post-confluent cells
The glucose-and fructose-consumption rates, glycogen content and lactate production of the cells at day 30 of culture were measured to establish whether the expression of GLUT5 could be correlated to the variation of these parameters. Hexosedeprived cells lost essentially all (90 %) their glycogen ( (Table 1) . On the contrary, no such correlation is found for the effect of glucose or fructose on the expression of GLUT5 in normal serum. Indeed the highest expression of GLUT5 mRNA occurs in glucose-fed (7) 164±+17 (6) 179+28 (4) 150±4 (4) 174 +3 (3) 192±9 (4) 423 + 25 (16) 333 + 28 (13) 32±5 ( (Table 1) .
DISCUSSION
Glucose, fructose and serum are involved in the regulation of the fructose transporter GLUT5 in the Caco-2/PD7 clone. In dialysed serum, fructose was the best stimulator of GLUT5 expression, whereas glucose-and hexose-deprived cells exhibited low and essentially no expression respectively. This hierachy was different in normal serum-fed cells where glucose is the best inducer. Fructose, however, yielded essentially the same level of GLUT5 mRNA abundance in dialysed and normal serum. Serum therefore mainly affects the expression of GLUT5 in glucose-fed cells, indicating that Caco-2 cells utilize glucose and fructose differently even though both sugars are used as energy and carbon sources [36] . In effect, Caco-2 cells produce lactate and synthesize glycogen from fructose or glucose. The effect of glucose and fructose on GLUT5 protein and mRNA abundances was reversible and specific, since DPPIV mRNA abundance and activity were not modified under any of the culture conditions used in this study.
Reversible fructose enhancement of the mRNA and protein abundance of GLUT5 have also been demonstrated in rats fed fructose-enriched diets [18] [19] [20] , indicating that a common mechanism of control of the expression of the fructose transporter is shared by human and rat intestinal cells. However, in rat small intestine, glucose did not appear to induce the transcription of the GLUT5 gene [18] [19] [20] . It cannot be excluded that the stimulation provided by blood glucose-supplies could be sufficient to induce GLUT5 expression at a basal level of abundance even though the control diet is devoid of any hexose [18] .
GLUT5 protein abundance in cells fed monosaccharides paralleled that of mRNA, indicating that the expression of the gene is not regulated at the translational level in Caco-2 cells. Protein and mRNA abundances exhibit different time-courses of regulation, a longer time being necessary to obtain a stabilized level of protein than that necessary to stabilize mRNA levels (compare GLUT5 mRNA and protein abundances in Figures 1  and 4) . These results are in contrast with those obtained in rat small intestine where the fructose-enriched diet had a 3-to 4-fold stronger effect on protein abundance than on mRNA levels [19, 20] . Fructose-enriched diets induced stimulated fructose uptake 2.5-fold in the rat [13, 17] , a value similar to that obtained for mRNA abundance but lower than that for protein. In human small intestine, not only fructose but also glucose, stimulates fructose uptake (reviewed in [37] ), suggesting that rodents and normal human enterocytes or Caco-2 cells may display different mechanisms for the control of the abundance of the fructose carrier.
The question now arises of the identification of the signal(s) that are responsible for the increase in GLUT5 mRNA and protein abundances in human intestinal cells. The answers presently offered are: the metabolic hypothesis, supported by the difference of expression observed in high-and low-glucoseconsuming Caco-2 clones which express low and high GLUT5 mRNA abundances respectively [24] ; and the hypothesis that a fructose and/or glucose sensor could be involved in the expression of hexose transporters, as proposed for SGLT1 in sheep [38, 39] and rodents [40, 41] small intestine. Our results do not favour one or the other of these proposals because GLUT5 is reversibly modulated in differentiated cells which were seeded in glucose media.
The GLUT5 gene is up-regulated by cAMP [27] . Under the standard conditions of culture, i.e. normal serum and 25 mM glucose, the presence of neuropeptides that activate adenylate cyclase yield constitutive and permanent activation of the transcription of the gene. This effect is in contrast to that seen in PD7 cells cultured in dialysed as compared with normal serum. Indeed the cAMP levels of glucose-fed cells are lowered by two-thirds in dialysed serum, thus explaining the sharp decrease in GLUT5 mRNA abundance observed in response to a medium change from normal to dialysed serum. In fructose-fed cells, cAMP levels were 10-fold higher than those obtained in hexose-free DMEM and yielded high mRNA and protein abundances which did not depend on the type of serum. In dialysed serum only, the expression of GLUT5 was directly related to the increase in cAMP concentrations in the cells. In normal serum, glucose was the best inducer, although cAMP levels are essentially not modified by addition of glucose to the culture media. Normal serum contains not only adenylate-cyclase activators but also small molecules which may be important co-factors for the metabolic fate of glucose. Therefore we conclude that not only cAMP but also the utilization of glucose by the cells is involved in the expression of GLUT5.
More work is obviously needed to compare and contrast the results obtained in Caco-2 cells and normal human small intestinal absorbing cells. Nevertheless, the present study describes a first attempt to understand the molecular mechanisms by which the GLUT5 transporter is regulated by sugar in human cells. Our results demonstrate that monosaccharides and cAMP are essential for the expression of the GLUT5 gene in Caco-2 cells. Fructose induction seems to rely exclusively on the increment of cAMP and of its transduction pathways, whereas additional intermediates are required for the full activation of the expression of GLUT5 by glucose. 
